France· FR:63688752
OMNIPAQUE 180 mg d'I/mL, solution injectable
A iohexol product containing iohexol, registered in France by GE HEALTHCARE, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Iohexol is registered in 17 of 19 countries.
Countries holding a registration under ATC V08AB02 (iohexol), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Iohexol · ATC V08AB02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IOHEXOL
- Manufacturer
- GE HEALTHCARE
- Country
- France (FR)
- ATC code
- V08AB02
- ATC class
- Iohexol
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
1 priced- cip1334009326810511 flacon(s) en verre de 10 mlEUR 2.41
- cip13340095721069410 flacon(s) en verre de 10 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
353 interactions on record for iohexol.
Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iohexol · interactions on record
353 records
- 286 severe
- 54 moderate
- 13 info
Most severe, free to view
- MetoclopramideA03FA01severe
- ThiethylperazinA04AB03severe
- TriflupromazinA04AD06severe
- DronabinolA04AD10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Iohexol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOmnipaque 180 mg I/mlGE Healthcare
- United KingdomOmnipaque 180 solution for injection 15ml vialsGE Healthcare Ltd
- IrelandOmnipaque 180 mg I/ml Solution for Injection (Glass)GE Healthcare AS
- NorwayOmnipaqueGE Healthcare AS
- SwedenOmnipaque 180 mg I/ml Injektionsvätska, lösningGE Healthcare AS
- JapanイオヘキソールGEヘルスケアファーマ
- CzechiaOMNIPAQUEGE Healthcare AS, Oslo
- United StatesIohexolAmneal Pharmaceuticals Private Limited
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Accupaque, Iovision
- Belgium · Omnipaque
- Bulgaria · Kopaq, Контамедиа Йох
- Cyprus · Omnipaque
- Czechia · Omnipaque
- Germany · Accupaque, Iovision
- Estonia · Iohexol Imax, Omnipaque
- Spain · Omnipaque
- Finland · Omnipaque
- United Kingdom (Northern Ireland) · Iohexol Farmak Pharmaceuticals Uk, Iohexol Ge Healthcare
- Greece · Omnipaque
- Croatia · Omnipaque
- Hungary · Iohexol Wogen, Omnipaque
- Ireland · Omnipaque
- Iceland · Omnipaque
- Italy · Omnipaque
- Lithuania · Iohexol Icg Farma, Iohexol Imax
- Luxembourg · Omnipaque
- Latvia · Iohexol Imax, Omnipaque
- Malta · Omnipaque
- Netherlands · Iohexol Adoh, Omnipaque
- Norway · Omnipaque
- Poland · Omnipaque
- Portugal · Iohexol Imax, Omnipaque
- Romania · Omnipaque
- Sweden · Iovision, Omnipaque
- Slovenia · Omnipaque
- Slovakia · Omnipaque
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2653120f-14a4-437a-8d4f-42ba00c24140 GET /v1/drugs/2653120f-14a4-437a-8d4f-42ba00c24140?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63688752",
"date_amm": "1984-04-16",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "IOHEXOL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intrathécale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about iohexol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.